NPPA Fixes Retail Price Of 41 Formulations; Details Medical Dialogues Team19 March 2021 1:44 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Diabetes drug, Metformin may decrease risk of skin cancer, finds study MD Bureau10 March 2021 4:30 PM ISTBasal cell carcinoma (BCC) is the most common cancer in white populations, and associated healthcare costs have become an increasing burden. A recent...
Metformin and Vitamin D Improve Clinical Outcomes of Cholangiocarcinoma: Study MD Bureau1 March 2021 5:45 AM ISTCholangiocarcinoma (CCA) is the most common biliary malignancy and the second most common hepatic malignancy after hepatocellular carcinoma (HCC). A...
Prolonged metformin treatment tied to more severe neuropathic pain in diabetics: Study Medha Baranwal28 Feb 2021 11:10 PM ISTEgypt: Diabetes patients treated with prolonged and higher doses of metformin are at a higher risk of more severe diabetic peripheral neuropathy (DPN)...
Metformin may help reduce weight and insulin resistance in obese children: Study Medha Baranwal26 Feb 2021 11:00 AM ISTCanada: Diabetes drug metformin yielded modest but favorable effects on insulin resistance and weight in obese children and adolescents, according to...
NPPA fixes retail price of Vildagliptin, Metformin Hydrochloride FDCs made by Macleods Farhat Nasim16 Feb 2021 5:35 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of Fixed-Dose Combination (FDC) of Vildagliptin and...
NPPA fixes retail price of 13 formulations; Details Ruchika Sharma13 Feb 2021 2:20 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority(NPPA), Ministry of Chemicals and Fertilizers, Government of...
Evogliptin and metformin combo effective for type 2 diabetes treatment: JAPI Medha Baranwal4 Feb 2021 3:15 PM ISTMumbai, Maharashtra: Combination therapy of Evogliptin and Metformin could be a promising treatment strategy for type 2 diabetes (T2D), finds a recent...
Ipragliflozin Vs Sitagliptin in T2D with Metformin: A glimpse of NISM study MD Bureau2 Feb 2021 9:46 PM ISTAccording to US and European guidelines, sodium - glucose co - transporter - 2 (SGLT2) inhibitors are considered second‐line drugs after metformin for...
Low Dose of Metformin May Prevent Development of AMD: JAMA Study MD Bureau30 Jan 2021 11:15 AM ISTMetformin, classified as biguanide, is the first - line and most widely used medication for patients with type 2 diabetes. In addition to its main...
Long-term use of metformin may reduce breast cancer risk in diabetes patients Dr. Kamal Kant Kohli29 Jan 2021 7:18 AM ISTResearchers have found in a new study that long-term use of metformin may reduce breast cancer risk associated with T2D. In the study metformin use in...
Metformin has cardiorenal safety in diabetics with CKD but may not decrease MACE Dr. Nandita Mohan21 Jan 2021 10:44 AM ISTResearchers have recently found that participants with chronic kidney disease from two cardiovascular outcomes trials support the cardiorenal safety...
